Background and Objective:
Translocator protein 18 kDa (TSPO) positron emission tomography (PET) imaging is used to monitor glial activation. Recent studies have proposed TSPO PET as a marker of the epileptogenic zone (EZ) in drug-resistant focal epilepsy (DRFE). This study aims to assess the contributions of TSPO imaging using [18F]DPA-714 PET and [18F]FDG PET for localizing the EZ during pre-surgical assessment of DRFE, when phase 1 pre-surgical assessment does not provide enough information.
Methods:
We compared [18F]FDG and [18F]DPA-714 PET images of 23 patients who had undergone a phase 1 pre-surgical assessment, using qualitative visual analysis and quantitative analysis, at both the voxel and the regional levels. PET abnormalities (increase in binding for [18F]DPA-714 vs decrease in binding for [18F]FDG) were compared with clinical hypotheses concerning the localization of the EZ based on phase 1 pre-surgical assessment. The additional value of [18F]DPA-714 PET imaging to [18F]FDG for refining the localization of the EZ was assessed. To strengthen the visual analysis, [18F]DPA-714 PET imaging were also reviewed by two experienced clinicians blind to the EZ location.
Results:
The study included 23 patients. Visual analysis of [18F]DPA-714 PET was significantly more accurate than [18F]FDG PET to both, show anomalies (95.7% vs 56.5%, p=0.022) and provide additional information to refine the EZ localization (65.2% vs 17.4%, p=0.019). All 10 patients with normal [18F]FDG PET had anomalies when using [18F]DPA-714 PET. The additional value of [18F]DPA-714 PET appeared to be greater in patients with normal brain MRI or with neocortical EZ (especially if insula is involved). Regional analysis of [18F]DPA-714 and [18F]FDG PET provided similar results. However, using voxel-wise analysis, [18F]DPA-714 was more effective than [18F]FDG for unveiling clusters whose localization was more often consistent with the EZ hypothesis (87.0% vs 39.1%, p=0.019). Non-relevant bindings were seen in 14 of 23 patients in visual analysis, and in 9 patients out of 23 in voxel-wise analysis.
Conclusion:
[18F]DPA-714 PET imaging provides valuable information for pre-surgical assessments of patients with DRFE. TSPO PET could become an additional tool to help to the localization of the EZ, especially in patients with negative [18F]FDG PET.
Classification of Evidence:
This study provide Class IV evidence on the utility of [18F]DPA-714 PET compared to [18F]FDG PET in identifying the epileptic zone in patients undergoing phase 1 pre-surgical evaluation for intractable epilepsy.